comparemela.com

Latest Breaking News On - Edendale lodge - Page 1 : comparemela.com

Battle care home s excitement over What A Great Idea campaign recognition

Edendale Lodge Care Home was humming with excitement and pride after being recognised in a group wide 'What a Great Idea' campaign. This initiative celebrates practical, innovative solutions and suggestions by members of the care team.

Edendale Lodge Care Home in Crowhurst receives a beacon of hope in uplifting service

Edendale Lodge Care Home in Crowhurst receives a beacon of hope in uplifting service
sussexexpress.co.uk - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from sussexexpress.co.uk Daily Mail and Mail on Sunday newspapers.

Battle care home honours exceptional Employee of the Month

Carer, Barry Warth has been named Edendale Lodge's Employee of the Month. This recognition highlights Barry's unwavering commitment to his role and his exceptional contributions to the care home community.

UK: Pandemic death toll among care home residents soars past 50,000

UK: Pandemic death toll among care home residents soars past 50,000
wsws.org - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from wsws.org Daily Mail and Mail on Sunday newspapers.

Covid-19 news archive: January 2021

Virginia Mayo/AP/Shutterstock Vaccines from Johnson & Johnson and Novavax report positive trial results A coronavirus vaccine developed by the US firm Novavax has been shown to be 89 per cent effective in preventing covid-19 in clinical trials. The trials included participants in the UK and South Africa, and found the vaccine to be 86 per cent effective against the UK variant of the virus, but only 60 per cent effective against the variant in South Africa. Novavax said it will immediately begin development on a vaccine specifically targeted to the South African variant. Advertisement Janssen, a subsidiary of US firm Johnson & Johnson, announced that its covid-19 vaccine showed 66 per cent efficacy in an international trial. These results are based on a single dose of the vaccine, which makes it easier to administer than the two-shot vaccines that have already been approved. The company has said it will sell its vaccine on a not-for-profit basis.

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.